发明名称 METABOLICALLY OPTIMIZED CELL CULTURE
摘要 Improved methods for large scale production of proteins and/or polypeptides in cell culture is provided. In accordance with the present invention, the method provides for culturing cells that have metabolically shifted. The use of such a method or system allows high levels of protein or polypeptide production and reduces accumulation of unwanted metabolic waste such as lactate. Proteins and polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, immunogenic, or other commercial biologic compositions, such as antibodies.
申请公布号 US2016230204(A1) 申请公布日期 2016.08.11
申请号 US201615130611 申请日期 2016.04.15
申请人 REGENERON PHARMACEUTICALS, INC. 发明人 Lawrence Shawn;LaFond Michelle;Kim Ann;Johnson Amy S.;Veres Brandon;Czeterko Mark;Whalen Kristen
分类号 C12P21/00;C07K16/00;C12Q3/00 主分类号 C12P21/00
代理机构 代理人
主权项 1. A method for culturing cells comprising: (a) culturing cells in a first cell culture; (b) determining a metabolic shift to lactate consumption has occurred in said first cell culture; (c) transferring an amount of cells from said first cell culture to a second cell culture after the metabolic shift to lactate consumption in the cells of said first cell culture has occurred; (d) culturing said cells in a second cell culture; and (e) transferring an amount of cells from said second cell culture to a production cell culture after said cells in the second cell culture have reached a predetermined viable cell concentration.
地址 Tarrytown NY US